Research Studies

Browse Studies

LUMA Study (Biogen)

Enrolling
Not Enrolling
Conditions:
PD

Criteria

Ages
30-80
Cognition
FALSE
Dyskinesias
no
Fluctuations
FALSE
Tremor
any
Gait
any
DBS
FALSE
Hallucinations
FALSE

About this study

The goal of this study is to investigate whether BIIB122 (study drug) may delay progression of PD. You may be eligible to participate if you are between 30 to 80 years of age and have been recently diagnosed with early-stage PD.

Sustain our mission to enhance lives and outcomes through research

As we work to improve patient quality of life — for their entire lifespan — we seek partners to catapult our progress. With your philanthropic investment, we can expand the breadth and depth of our efforts in three critical areas: research, clinical care and education and training.

Support Us